BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 24440369)

  • 1. Psychostimulants and brain dysfunction: a review of the relevant neurotoxic effects.
    Gonçalves J; Baptista S; Silva AP
    Neuropharmacology; 2014 Dec; 87():135-49. PubMed ID: 24440369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs.
    Cunha-Oliveira T; Rego AC; Oliveira CR
    Brain Res Rev; 2008 Jun; 58(1):192-208. PubMed ID: 18440072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drugs of abuse-induced hyperthermia, blood-brain barrier dysfunction and neurotoxicity: neuroprotective effects of a new antioxidant compound H-290/51.
    Sharma HS; Sjöquist PO; Ali SF
    Curr Pharm Des; 2007; 13(18):1903-23. PubMed ID: 17584116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of blood-brain barrier dysfunction in methamphetamine abuse.
    Pang L; Wang Y
    Biomed Pharmacother; 2023 May; 161():114478. PubMed ID: 37002574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain injury associated with widely abused amphetamines: neuroinflammation, neurogenesis and blood-brain barrier.
    Silva AP; Martins T; Baptista S; Gonçalves J; Agasse F; Malva JO
    Curr Drug Abuse Rev; 2010 Dec; 3(4):239-54. PubMed ID: 21208167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms.
    Cadet JL; Krasnova IN; Jayanthi S; Lyles J
    Neurotox Res; 2007 Apr; 11(3-4):183-202. PubMed ID: 17449459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current preclinical studies on neuroinflammation and changes in blood-brain barrier integrity by MDMA and methamphetamine.
    O'Shea E; Urrutia A; Green AR; Colado MI
    Neuropharmacology; 2014 Dec; 87():125-34. PubMed ID: 24594477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preface: New concepts of psychostimulants induced neurotoxicity.
    Sharma HS
    Int Rev Neurobiol; 2009; 88():xv-xvi. PubMed ID: 19897071
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of psychostimulants on neurotrophins implications for psychostimulant-induced neurotoxicity.
    Angelucci F; Ricci V; Spalletta G; Caltagirone C; Mathé AA; Bria P
    Int Rev Neurobiol; 2009; 88():1-24. PubMed ID: 19897072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of in vivo drug-induced neurotoxicity models.
    Sharma HS; Menon P; Lafuente JV; Muresanu DF; Tian ZR; Patnaik R; Sharma A
    Expert Opin Drug Metab Toxicol; 2014 Dec; 10(12):1637-61. PubMed ID: 25311945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drugs of abuse and blood-brain barrier endothelial dysfunction: A focus on the role of oxidative stress.
    Sajja RK; Rahman S; Cucullo L
    J Cereb Blood Flow Metab; 2016 Mar; 36(3):539-54. PubMed ID: 26661236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondria: key players in the neurotoxic effects of amphetamines.
    Barbosa DJ; Capela JP; Feio-Azevedo R; Teixeira-Gomes A; Bastos Mde L; Carvalho F
    Arch Toxicol; 2015 Oct; 89(10):1695-725. PubMed ID: 25743372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive deficits and neurotoxicity induced by synthetic cathinones: is there a role for neuroinflammation?
    Leyrer-Jackson JM; Nagy EK; Olive MF
    Psychopharmacology (Berl); 2019 Mar; 236(3):1079-1095. PubMed ID: 30368582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designer psychostimulants: pharmacology and differences.
    Iversen L; White M; Treble R
    Neuropharmacology; 2014 Dec; 87():59-65. PubMed ID: 24456744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial oxidative stress and dysfunction in arsenic neurotoxicity: A review.
    Prakash C; Soni M; Kumar V
    J Appl Toxicol; 2016 Feb; 36(2):179-88. PubMed ID: 26510484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine toxicities: classical and emerging mechanisms.
    Yamamoto BK; Moszczynska A; Gudelsky GA
    Ann N Y Acad Sci; 2010 Feb; 1187():101-21. PubMed ID: 20201848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurotoxicity of amphetamines during the adolescent period.
    Teixeira-Gomes A; Costa VM; Feio-Azevedo R; Bastos Mde L; Carvalho F; Capela JP
    Int J Dev Neurosci; 2015 Apr; 41():44-62. PubMed ID: 25482046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathways of mitochondrial dysfunctions: possible cause of cell death in anesthesia-induced developmental neurotoxicity.
    Li L; Yu Q; Liang W
    Brain Res Bull; 2015 Jan; 110():14-9. PubMed ID: 25451455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of nicotinic receptors in methamphetamine- and MDMA-induced neurotoxicity: pharmacological implications.
    Escubedo E; Camarasa J; Chipana C; García-Ratés S; Pubill D
    Int Rev Neurobiol; 2009; 88():121-66. PubMed ID: 19897077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity.
    Kita T; Miyazaki I; Asanuma M; Takeshima M; Wagner GC
    Int Rev Neurobiol; 2009; 88():43-64. PubMed ID: 19897074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.